all-cis-5,8,11,14,17-icosapentaenoic acid/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases erythrocyte sedimentation rate
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“Serum ESR and CRP levels significantly decreased in the EPA-rich fish oil (p < 0.001).”
Quoted verbatim from Eicosapentaenoic acid decreases inflammation and improves glucose homeostasis in patients with burns: a randomized clinical trial.. - Study
- RCT
- Participants
- 24
- Duration
- 3 weeks
- Dose
- 1.5 g/day EPA as EPA-rich fish oil capsules (500 mg EPA per capsule, three times daily with meals)
- Population
- Hospitalised adults aged 18-65 with non-severe burns covering less than 20% of total body surface area, able to take more than 90% of their daily calorie requirement by mouth, without diabetes, organ failure, cancer or immune disorder; both the EPA arm and the control arm also received 600 mg/day DHA.
Eicosapentaenoic acid decreases inflammation and improves glucose homeostasis in patients with burns: a randomized clinical trial.2025PMID:41254027Permalink
Keep reading
- Everything the graph holds on all-cis-5,8,11,14,17-icosapentaenoic acid
- Every compound studied against Erythrocyte sedimentation rate
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M10HW3BPTJAZ0X44NRQAS9TN